ArticleMolecular imaging and radionuclide therapy2025
Correlation of 3T Diffusion-weighted MRI and
Article in Molecular imaging and radionuclide therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A study on screening of postoperative chemotherapy beneficial populations in stage II colorectal cancer based on diffusion weighted imaging andJournal of gastrointestinal oncology · 2026Article
- Comparative study of total-body PET and PET/MR in the diagnosis of liver metastases.Frontiers in oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Positron emission tomography/computed tomography (PET/CT) and magnetic resonance imaging (MRI) are widely used in the diagnosis and follow-up of liver metastases. Both modalities provide anatomical and functional information and have advantages and disadvantages. The objective of this study was to investigate the correlation between apparent diffusion coefficient (ADC) and standardized uptake value (SUV) values in metastatic liver lesions. Methods: Abdominal magnetic resonance (MR) scans performed between April 2021 and 2024 using the 3T MR scanner were retrospectively evaluated. Thirty-three patients with liver metastases, less than one month between magnetic resonance imaging (MRI) and PET/CT, no treatment during this period, and lesions larger than 1 cm were included in the study. In each MRI scan, an index lesion was selected for ADC measurement. The radiologist and nuclear medicine specialist measured the same index lesion without the patient being informed of the results. Results: The mean age of the 33 patients was 59±12 years, with 17 (51%) men and 16 (49%) women. The mean size of the index lesions was 27±9 mm. In MRI, mean ADC Conclusion: There was no correlation between ADC and SUV values in liver metastases. Prospective studies with a large patient group are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.